Motexafin gadolinium (MGd) was used as a 2 mM (2.3 mg/mL) formulation in 5% aqueous mannitol. Zinc acetate (99.99%, ZnOAc 2 ) was purchased from Aldrich Chemical Co. and prepared as a 2 mM formulation in 5% aqueous mannitol. PCI-5002 and PCI-5003, synthesized as described below, were formulated in 5% mannitol at 2 to 8 mM concentrations for both in vitro and in vivo experiments. PCI-5001 and the zinc salt of 1-hydroxypyridine-2-thione (ZnHPT, Sigma Chemical) were formulated in DMSO for in vitro experiments. The zinc-free ligands were freely soluble in aqueous media. The lowest energy extinction coefficient of ZnHPT ( 280 = 22,082 M -1 cm -1 ; 332 = 6,187 M -1 cm -1 ; DMSO) was used to quantify solutions of ZnHPT analogues, which were in some cases isolated as oils. 
synthesized as described below, were formulated in 5% mannitol at 2 to 8 mM concentrations for both in vitro and in vivo experiments. PCI-5001 and the zinc salt of 1-hydroxypyridine-2-thione (4000 cells/well) cells were seeded on 96-well microtiter plates and allowed to adhere overnight.
Stock solutions of ZnHPT or analogues in medium were serially diluted in a ratio of 1:4. Stock solutions of MGd or ZnOAc 2 or 5% mannitol in ACS grade water were added and plates were incubated at 37 o C under a 5% CO 2 /95% air atmosphere. After 72 hours, medium was replaced with fresh medium (150 L/well) supplemented with the tetrazolium dye, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma Chemical, 0.5 mg/mL).
Plates were incubated at 37 o C and viable cells measured as described (1) . Cellular reduction within plateau phase cultures was measured as above after 24 hours of treatment.
Lipoate Reduction. Thioredoxin reductase activity was assessed by measuring the rate of lipoate reduction (2) . In brief, A549 or PC3 cells (10,000 cells/well) were seeded on 96-well plates and allowed to adhere overnight and grow two additional days until confluent. Cells were treated with ZnHPT, ZnHPT analogues, zinc, or 5% mannitol as described above for 2 or 4
hours. Medium was removed, cells were washed with Hanks balanced salt solution (HBSS), and a solution of 5 mM lipoic acid and 1 mM 5,5'-dithiobis(2-nitrobenzoic acid) in HBSS (100 L/well) was added. Plates were incubated at ambient temperature in the dark. At chosen time intervals, plate absorbances were measured at 405-650 nm. Rates were normalized to those of wells containing neither exogenous zinc nor ZnHPT analogues to allow plate-to-plate comparison.
Intracellular Free Zinc and Cell Viability. The concentration of intracellular free zinc
was assessed using the ion-specific fluorescent probe, FluoZin-3-AM ™ (FluoZin-3, Molecular Probes, Inc.) (3) . Plateau phase cultures were treated with control 5% mannitol vehicle or ZnOAc 2 in the presence or absence of ZnHPT or ZnHPT analogues for 4 hours. Following treatment, cells were isolated by centrifugation. Cell pellets were washed and re-suspended in a solution of 0.5% BSA in PBS. An aliquot of 10 6 cells (200 L) was removed, centrifuged, and treated with FluoZin-3 reaction buffer as described (3) . An aliquot of the cell suspension was supplemented with 2 g/mL propidium iodide (Sigma Biochemical), incubated for 5 minutes, and subjected to two-parameter flow cytometric analysis as described previously (4) . Cell viability and apoptosis in like-treated plateau phase cultures was measured using the ANNEXIN-V PI Kit (BD Biosciences, San Jose, CA) after 24 hours of treatment as described (5) .
Measurement of reactive oxygen species (ROS).
Reactive oxygen species were measured in live cells as intracellular peroxides by monitoring the oxidation of 2',7'-dichlorofluorescin-diacetate (DCFA) to 2',7'-dichlorofluorescein (DCF) (Molecular Probes).
Cells (1 x 10 6 per mL) were incubated in a solution of 1 g per mL DCFA in 0.5% BSA in HBSS for 15 minutes at 37 o C. Two mL additional 0.5% BSA in HBSS was added, cells were isolated by centrifugation, and the pellet re-suspended in a solution of 50 g/mL 7-aminoactinomycin D (7-AAD) in 0.5% BSA in HBSS. Cell suspensions were incubated at ambient temperature for 2 to 3 minutes, and stored on ice until analysis. The fluorescent intensity in live (i.e., 7-AAD impermeable) cells was analyzed by flow cytometry. 
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Synthesis of PCI-5001, PCI-5002, and PCI-5003
General. All starting materials were purchased and used without further purification unless otherwise noted. Proton and 13 C NMR spectra were recorded using a 250 MHz Varian, 300
MHz GE Tacmag The mixture was concentrated under reduced pressure and 20 mL of CH 2 Cl 2 was added to dissolve the product. The inorganic salts were removed by vacuum filtration, and the filtrate was concentrated on a rotary evaporator. Column chromatography on silica gel using CH 2 Cl 2 as the eluent yielded 1.1g PEGylation product 3b (90%). DCM, rt n n 3a: n = 0 3b: n = 1 3c: n = 2 4a: n = 0 4b: n = 1 4c: n = 2
2-Bromo
The oxidation reactions of 3a-c were carried out following the same procedure. An example is given below: To a solution of 2-Bromo-5-CH 2 PEG(2)-pyridine (3b, 1.1g, 3.79mmol) in 15mL of CH 2 Cl 2 was added 3-chloroperoxybenzoic acid (1.7g, 7.58mmol). After being stirred at room temperature overnight, the reaction mixture was concentrated under reduced pressure. Deionized water (DI H 2 O, 10 mL) was added to dissolve the product. The insoluble solid was removed by vacuum filtration and the solid on the funnel was washed with DI H 2 O (5mL x 2).
The combined filtrate and washings were loaded on a tC-18 Sep-pak column and purified to provide 950mg (82%) of 4b. was added dropwise via a syringe over a period of 1h. The reaction mixture was allowed to stir for an additional 1 h. After cooling to room temperature, acetic acid was added to adjust pH to 5.
The mixture was concentrated under vacuum to give 5b as yellow oil, which was used in the next reaction without further purification. Small amounts of analytical samples were prepared by silica gel column chromatography followed by Sep-Pak treatment. 
2-Mercapto-5-((2-methoxyethoxy)methyl)pyridine-N-oxide (5a
